Clinical trial
Evaluation of Host Biomarker-based Point-of-care Tests for Targeted Screening for Active TB
NCT03350048 is registered in ClinicalTrials.gov with Prof Gerhard Walzl as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Host Biomarker-based Point-of-care Tests for Targeted Screening for Active TB
- Lead sponsor
- Prof Gerhard Walzl
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 1, 2016
- Completion date
- July 31, 2020
- Enrollment
- 969 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
pulmonary tuberculosis